NCT00189761View on ClinicalTrials.gov

A Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in BMT Recipients

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Bone Marrow TransplantationGraft Versus Host DiseaseGraft-Vs-Host DiseaseGraft-Versus-Host Disease
Interventions
DRUG

Tacrolimus

Trial Locations (4)

Unknown

Chubu Region

Hokkaido Region

Kanto Region

Kyusyu Region

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT00189761 - A Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in BMT Recipients | Biotech Hunter | Biotech Hunter